An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), has developed the drug, in collaboration with Dr Reddy’s Laboratories, Hyderabad.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by day-3 in comparison to SOC, indicating an early relief from oxygen therapy/dependence. The drug comes in the form of a powder in a sachet & is supposed to be dissolved in water.
Important takeaways for all competitive exams:
India has achieved remarkable success in space and missile technology, thanks to the efforts of…
The entertainment industry has always captivated audiences, especially through the work of actors who have…
Makar Sankranti is a vibrant and ancient Hindu festival that celebrates the Sun's movement from…
The ICC Champions Trophy, often nicknamed the "Mini World Cup," was introduced by the International…
In India, many cities and districts are known for their unique specialties. One such place…
India is home to some of the busiest cities in the world, where work, culture…